NICHOLAS PETERS: Open Payments
NPI 1407598428 · KANNAPOLIS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 58 payments from 14 companies in 2025. Trend: 2023 $220 · 2024 $1,134 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $335 |
| AstraZeneca Pharmaceuticals LP | 3 | $263 |
| ABBVIE INC. | 10 | $225 |
| Novo Nordisk Inc | 9 | $194 |
| Lilly USA, LLC | 9 | $170 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Exact Sciences Corporation | 3 | $59 |
| PFIZER INC. | 3 | $52 |
| Corcept Therapeutics | 1 | $27 |
Products named: MOUNJARO, QULIPTA, REPATHA, AIRSUPRA, BEVESPI AEROSPHERE, Ozempic, TRELEGY ELLIPTA, OTEZLA.
Industry payments across NC — which companies pay providers there.
